Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2016-01-12

Clinical Trial Update: Genomic Research in Alpha-1 Antitrypsin Deficiency

View source ↗

Summary

The update summarizes the completion of a genomic research study in Alpha-1 Antitrypsin Deficiency (AATD).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of Pittsburgh | Conditions: Alpha 1 Antitrypsin Deficiency, AATD | Status: COMPLETED